An SV40-adenovirus type 7 "hybrid" population with several distinct properties has recently been described. ["Hybrid" is being used to denote a stable virus population possessing determinants of two distinct parental types but coated by the protein of one parent only. It does not imply a direct interaction between the nucleic acids of the parental types.] The virus can induce the synthesis of SV40 tumor (T) antigen in green monkey kidney (GMK) cells, but neither SV40 virus antigen nor infectious SV40 can be detected (10, 23, 26) . The SV40 T antigen induced by the hybrid population is immunologically indistinguishable from that present during the early stages of the SV40 cytolytic cycle (9, 19, 22, 29) or from the T antigen synthesized in cells transformed by SV40 (3, 7, 17, 20) . Induction of the SV40 T antigen and replication of the hybrid virus are both inhibited by adenovirus type 7 antiserum, but these properties are unaffected by serum prepared against either SV40 or against the T antigen (10, 23, 26) . Recent studies have demonstrated that the hybrid population consists of at least two distinct particles. Both are required to initiate plaque formation in GMK cells (27; Boeye, Melnick, and Rapp, Virology, in press), and progeny derived from such plaques carry the SV40 determinant for T antigen (4, 21, 27) . The determinant is not present, however, in plaque progeny obtained from human embryonic kidney (HEK) cells (4, 27) . One of the particles appears to contain the genome of the adenovirus; the SV40 determinant is carried in the second particle (21; Boeye et al., in press). Both particles, however, morphologically resemble adenovirions. The SV40 determinant can be transferred to other adenovirus types (21, 25 ) and it appears likely that the adenovirus supplies the information for the coat protein for both particles (21 Viruses. The SV40-adenovirus type 7 hybrid virus (stock SP2) has been described in detail (10, 23, 26) . Two additional passages of the virus were carried out in GMK cells prior to this study. SV40 was the Baylor reference strain described in previous reports from this laboratory (19, 22) . It was used after six passages in GMK cells.
Adenovirus type 7 (he) was isolated from the SP2 stock and plaque-purified three times in HEK cells by Boey6 et al. (4) . It was used after four additional passages in HEK cells and is free from SV40 T antigen determinants. Another strain of adenovirus type 7 (hu) was isolated from a fatal case of pneumonia (1) and has been passed only in HEK cells; it, too, does not contain detectable SV40 determinants.
Adenovirus type 2 was also a fresh human isolate and was supplied by M. Benyesh-Melnick. It was used after three passages in KB cells. Adenovirus type 12 was obtained originally from R. J. Huebner. It has been passed numerous times in KB cells and once in HEK cells. Neither virus carries detectable SV40 determinants.
All virus stocks were prepared in cells growing in 16-oz (454-g) bottles; virus was harvested by disrupting the cells in the medium. Cell debris was removed by low-speed centrifugation, and the supernatant fluid was dispensed in 1-ml amounts into glass ampoules; the ampoules were sealed, and the virus was then quick-frozen and stored at -90 C.
Antisera. Neutralizing antisera were prepared in rabbits against the type 7 (hu), type 2, and type 12 adenoviruses described above. Rabbits received one intramuscular injection weekly for 3 weeks, a fourth inoculation 2 weeks later, and were bled 2 weeks after the final inoculation.
Virus assays. Adenoviruses were titrated in HEK cells grown as monolayers in 35-mm plastic petri dishes (4, 6) . The cultures were incubated at 37 C in a 5% CO2 incubator. The hybrid virus was also assayed on GMK cell monolayers grown in 60-mm plastic petri dishes (4, 21) . In both assays, 0.1 ml of virus inoculum was allowed to adsorb for 1 hr at 37 C with frequent manual rotation; the 60-mm plates also received 0.2 ml of tris(hydroxymethyl)aminomethane (Tris) buffer as carrier fluid to facilitate even distritution of the virus. The overlay consisted of Eagle's basal medium, 10% FBS, 1% agar, and 0.23% sodium bicarbonate; 7 days later, a second overlay containing a 1:20,000 dilution of neutral red was added. Plaques were visible the next day, but maximal titers were not reached until the 11th to the 13th day after inoculation of the cultures. All titrations were carried out with two or three plates per dilution.
Enhancement experiments involving GMK cells were performed in the same manner as the assay, except that 0.1 ml of a high concentration of the helper adenovirus was inoculated and allowed to adsorb simultaneously with the inoculum being titrated.
Immunofluorescence techniques. Secondary cultures of GMK cells were grown on 15-mm cover slips in plastic petri dishes; 24 hr after being inoculated, the cells on the cover slips were washed with warm Tris buffer (pH 7.4) and fixed for 3 min in acetone. SV40 T antigen was detected (22) by treating the cells first with sera from hamsters bearing SV40-induced tumors and, second, with anti-hamster globulin prepared in rabbits and labeled with fluorescein isothiocyanate. Detailed fractionation and labeling methods have been described (12) . A Zeiss fluorescence microscope, with an Osram HBO-200 mercury arc vapor lamp for illumination, was used to examine the stained preparations. Each test included appropriate positive and negative controls.
RESULTS
Replication of an SV40-adenovirus type 7 hybrid in GMK cells. Replicate GMK cultures were infected with the hybrid (SP2) virus at an input multiplicity of 3 plaque-forming units (PFU)/cell, based on the SP2 titer obtained in HEK cells. Adenovirus type 7 (he) was inoculated onto GMK monolayers at an input multiplicity of 4 PFU/cell. Replicate cultures inoculated with adenovirus type 7 (he) also received SV40 at a multiplicity of infection of 2 PFU/cell. Virus was harvested from the three series of infected cultures at various times after inoculation, and adenovirus titers were obtained by plaquing on HEK cells. Adenovirus type 7 (in cultures inoculated only with that virus) gradually decreased in titer during the 72-hr observation period (Fig. 1) Heat-inactivated adenoviruses did not enhance plaque formation by SP2. SV40 also failed to enhance plaque titers of SP2. Filtration through Gradocol membranes revealed that the enhancing particle is in the size range of an adenovirus. The particle which interacted with the adenovirus to initiate plaque formation has previously been named PARA (Particle Aiding, and aided by, the Replication of Adenovirus; 21).
Transfer of PARA from adenovirus type 7 (SP2) to other adenoviruses. Under conditions of maximal enhancement with various adenoviruses, plaques were usually initiated by SP2 at dilutions 100-fold beyond the end point obtained in the absence of helper adenovirus. These terminal plaques were picked, the particles were passaged in GMK cells, and the progeny were studied. This was done to determine the nature of the particles which had interacted to form the plaques. All 35 plaques analyzed yielded progeny which were capable of inducing in GMK cells the synthesis of SV40 T antigen, detectable by immunofluorescence procedures. Neutralization tests revealed that the induction of the T antigen was not necessarily inhibited by antiserum against adenovirus 7, but rather by antiserum directed against the specific adenovirus which had acted as the enhancing virus (Table 2) . Progeny from SP2 plaques formed by enhancement with adenovirus type 2 were no longer antigenically type 7 adenoviruses, but were neutralized as though they were bearing the protein coat characteristic of adenovirus type 2. The progeny from one adenovirus type 2-enhanced plaque induced T antigen synthesis after neutralization with either adenovirus type 2 or type 7 antiserum. That population probably consisted of a mixture of antigenic types. Similar results were obtained with the progeny from adenovirus type 12-enhanced plaques, with the exception that three plaques yielded progeny which were still coated with adenovirus type 7 protein. These particular plaques had been picked at higher concentrations of hybrid inoculum because the concentration of coinfecting adenovirus 12 had not provided maximal enhancement. This technical problem undoubtedly increased the chances of picking plaques which had been initiated by superinfection with adenovirus type 7 from the SP2 inoculum. The ability of the progeny to plaque in GMK cells was also neutralized by appropriate antiserum. The results obtained are also in agreement with the hypothesis that the progeny from enhanced SP2 plaques acquire the antigenic properties of the helper virus. Numerous plaque progeny were tested; representative data are shown in Table 3 . Antiserum prepared against the human strain of adenovirus type 7 (hu) inhibited plaque formation by the parent SP2, but was without effect on progeny from terminal SP2 plaques formed by enhancement with heterologous adenoviruses. The latter progeny were, however, neutralized by specific antiserum against the enhancing virus, either adenovirus type 2 or type 12 ( Table 3) .
Neutralization of PARA by specific antiserum. Since PARA could not plaque on GMK cells in the absence of co-infecting adenovirus, the possibility existed that the neutralization results shown in Table 3 does not multiply in GMK cells (6; Feldman, Butel, and Rapp, J. Bacteriol., in press). The adenovirus in the SP2 population does multiply in GMK cells (Fig. 1) in the presence of the defective SV40 component (PARA). Replication of PARA. We have been unable to physically separate PARA and adenovirus in the hybrid virus population. This rendered studies of PARA replication more difficult. Several experimental approaches were therefore used.
Approach 1: GMK cells in 1-oz (28-g) bottles (about 106 cells) were infected with SP2 at a dilution calculated to introduce about 100 PFU of PARA per culture. The inoculum at this dilution contained about 50 PFU of adenovirus 7 . This low input multiplicity should have resulted in some cells being singly infected with PARA. Replicate bottles were inoculated with 4 PFU/cell of adenovirus type 7 (he) and 100 PFU of PARA per culture. This was to ensure that every PARA-infected cell would be jointly infected with adenovirus. Harvests were made 7 and 96 hr after infection, and were titrated in GMK cells saturated with helper adenovirus to titrate for PARA. Undiluted harvests taken 7 hr after inoculation did not cause the formation of plaques. Likewise, the undiluted 96-hr harvest from the culture inoculated only with SP2 did not yield plaques. However, the 96-hr harvest, from the culture receiving both SP2 and additional adenovirus type 7 contained 800 PFU of PARA per culture. Similar experiments, with adenovirus type 2 as helper virus, gave comparable results. Therefore, PARA replication in the presence of adenovirus was detected, but none could be detected in the absence of joint infection with adenovirus under otherwise identical conditions. Approach 2: The harvests from the SP2 growth in GMK cells used to study adenovirus replication (Fig. 1) were titered in GMK cells co-infected with helper adenovirus to enumerate PARA particles. The initial inoculum for this experiment contained about 2 PFU of PARA per cell and 4 PFU of adenovirus 7 per cell. Under conditions of joint infection, PARA underwent a cycle of replication (Fig. 2) closely paralleling that of the helper adenovirus 7 in the same system (sketched in from Fig. 1 for comparison purposes) .
Approach 3: GMK monolayers were inoculated with low multiplicities of SP2 and the cultures were incubated under fluid medium. Saturating amounts of helper adenovirus were added on successive days after infection, at which time an agar overlay was also added. If PARA could replicate unilaterally, spread and reinfection throughout the cultures should have occurred and those cultures maintained under fluid for progressively longer periods of time prior to the addition of adenovirus should have yielded increasing plaque counts. PARA titers obtained 13 days after the adenovirus was added are shown in Table 5 . It can be seen that PARA persisted at a near-constant level for 24 hr in the GMK cells, but the addition of adenovirus at later intervals revealed a progressive drop in titer. This suggests that PARA had not replicated until the adenovirus was added and had been gradually inactivated in the GMK cells prior to the addition of the adenovirus.
These experimental approaches, therefore, yielded evidence compatible with the concept that (5) . Satellite tobacco necrosis virus (STNV) is smaller and serologically unrelated to tobacco necrosis virus, but replicates only in its presence (11) . Reichmann (24) found that STNV contains only enough ribonucleic acid to code for 400 amino acids and that the coat protein subunit consists of 372 amino acids. He suggested that one protein is all the satellite virus can code for and that the satellite virus is dependent upon replicating necrosis virus for other needed factors.
The Bryan strain of Rous sarcoma virus (RSV) is a defective animal virus. It cannot direct the synthesis of coat protein and is dependent upon a helper virus, RAV, for its production (8) . Similarly, adenovirus must supply the capsid for PARA. The two systems are not strictly analogous, however, because both RSV and RAV can exercise independent functions in the absence of the other (28) . RSV can transform cells, and RAV can undergo a complete replicative cycle. We have been unable to detect any such perpetuating activity in simian cells by PARA or adenovirus, and neither can replicate in this type of cell independently. The defect which prevents adenovirus replication in monkey cells has not yet been determined. During joint infection, SV40 potentiates adenovirus multiplication (6, 15, 16, 18; Feldman et al., in press ). PARA serves the same function during replication of the adenovirus-SV40 hybrid populations.
The conversion of the capsid protein of PARA from that of one adenovirus type to that of another, with the retention of the SV40 determinants in a stable form, has been called transcapsidation (21) .
